David Elliot Eisenbud
Directeur Technique/Scientifique/R&D chez OcuNexus Therapeutics, Inc.
Profil
David Elliot Eisenbud was the founder of Shire Regenerative Medicine, Inc. founded in 2003, where he held the position of Chief Medical Officer & Executive VP until 2011.
He is currently the Medical Director at Overlook Hospital Foundation, Chief Medical Officer at OcuNexus Therapeutics, Inc., Chief Medical Officer at CoDa Therapeutics (NZ) Ltd., and Managing Partner at Millburn Surgical Associates.
Dr. Eisenbud's former positions include Vice President-Strategic Planning at TYRX, Inc., Manager at STRATA Skin Sciences, Inc., and Manager at EraGen Biosciences, Inc. He was also the President of American Academy of Wound Management in 2003.
Dr. Eisenbud's education history includes a graduate degree from The University of Chicago in 1979, an undergraduate degree from Yale University in 1976, an MBA from The Leonard N Stern School of Business in 1997, and a doctorate from Pritzker School of Medicine in 1981.
Postes actifs de David Elliot Eisenbud
| Sociétés | Poste | Début |
|---|---|---|
OcuNexus Therapeutics, Inc.
 OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 03/05/2011 |
| Millburn Surgical Associates | Corporate Officer/Principal | 02/06/2011 |
CoDa Therapeutics (NZ) Ltd.
 CoDa Therapeutics (NZ) Ltd. Pharmaceuticals: MajorHealth Technology CoDa Therapeutics (NZ) Ltd. develops and markets biopharmaceutical products. The company was founded by David Becker, Colin Green, Bradford J, Duft, and Howard E. Greene and on December 9, 2003 and is headquartered in Auckland, New Zealand. | Directeur Technique/Scientifique/R&D | 02/06/2011 |
Overlook Hospital Foundation
 Overlook Hospital Foundation Medical/Nursing ServicesHealth Services Overlook Hospital Foundation provides fund raising and community outreach services. It raises funds for equipment, facilities, and programs for Overlook Hospital. It specializes in cancer treatment, fundraising, healthcare, and investing. The company is headquartered in Summit, NJ. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de David Elliot Eisenbud
| Sociétés | Poste | Fin |
|---|---|---|
| American Academy of Wound Management | President | 01/01/2003 |
TYRX, Inc.
 TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology TYRX, Inc. designs and manufactures medical-pharmaceutical combination devices. The firm commercializes implantable combination drug and device products focused on infection control including the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs). Its AIGISRx products contain the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by pathogens responsible for the majority of CIED infections, including superbugs such as methicillin-resistant S. aureus (MRSA). The company was founded in 1998 by Satish Pulapura and Arikha Moses and is headquartered in Monmouth Junction, NJ. | Corporate Officer/Principal | - |
| STRATA SKIN SCIENCES, INC. | Corporate Officer/Principal | - |
EraGen Biosciences, Inc.
 EraGen Biosciences, Inc. Medical SpecialtiesHealth Technology EraGen Biosciences, Inc. is a venture-backed biotechnology company. It designs, develops, manufactures and markets molecular diagnostic testing products and software for the research and clinical testing markets. The firm in-market and pipeline products, based on its novel, patented MultiCode platform chemistry, are the next generation of nucleic acid-based testing for the early detection and monitoring of cancer, genetic and infectious diseases. The company was founded in 1994 and is headquartered in Madison WI. | Corporate Officer/Principal | - |
Shire Regenerative Medicine, Inc.
 Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT. | Fondateur | - |
Formation de David Elliot Eisenbud
| The University of Chicago | Graduate Degree |
| Yale University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
| Pritzker School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| STRATA SKIN SCIENCES, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
TYRX, Inc.
TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology TYRX, Inc. designs and manufactures medical-pharmaceutical combination devices. The firm commercializes implantable combination drug and device products focused on infection control including the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs). Its AIGISRx products contain the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by pathogens responsible for the majority of CIED infections, including superbugs such as methicillin-resistant S. aureus (MRSA). The company was founded in 1998 by Satish Pulapura and Arikha Moses and is headquartered in Monmouth Junction, NJ. | Electronic Technology |
Shire Regenerative Medicine, Inc.
Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT. | Health Technology |
OcuNexus Therapeutics, Inc.
OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA. | Health Technology |
EraGen Biosciences, Inc.
EraGen Biosciences, Inc. Medical SpecialtiesHealth Technology EraGen Biosciences, Inc. is a venture-backed biotechnology company. It designs, develops, manufactures and markets molecular diagnostic testing products and software for the research and clinical testing markets. The firm in-market and pipeline products, based on its novel, patented MultiCode platform chemistry, are the next generation of nucleic acid-based testing for the early detection and monitoring of cancer, genetic and infectious diseases. The company was founded in 1994 and is headquartered in Madison WI. | Health Technology |
| American Academy of Wound Management | |
CoDa Therapeutics (NZ) Ltd.
CoDa Therapeutics (NZ) Ltd. Pharmaceuticals: MajorHealth Technology CoDa Therapeutics (NZ) Ltd. develops and markets biopharmaceutical products. The company was founded by David Becker, Colin Green, Bradford J, Duft, and Howard E. Greene and on December 9, 2003 and is headquartered in Auckland, New Zealand. | Health Technology |
Overlook Hospital Foundation
Overlook Hospital Foundation Medical/Nursing ServicesHealth Services Overlook Hospital Foundation provides fund raising and community outreach services. It raises funds for equipment, facilities, and programs for Overlook Hospital. It specializes in cancer treatment, fundraising, healthcare, and investing. The company is headquartered in Summit, NJ. | Health Services |
| Millburn Surgical Associates |
